Welcome To
Stocks.
TRoach
.Net


email
[email protected]
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE:
This page is for evaluation of a JFF Project.
Information on this page or site should NOT
be used for investment purposes.



Curiosity Stocks - Price range: $0 - $1

6.0: AMBO : Ambow Education Holding Ltd. American Depository Shares each representing two Class A ordinary shares : ~ Price 0.15
Ambow Education Holding Ltd. is a leading national provider of educational and career enhancement services in China, offering high-quality, individualized services and products. With its extensive network of regional service hubs complemented by a dynamic proprietary learning platform and distributors, Ambow provides its services and products to students in 15 out of the 34 provinces and autonomous regions within China.
_ Company Web Site ____________ Summary Pages ____________ 11.185:35.0:4


6.0: PAYOW : Payoneer Global Inc. Warrant : ~ Price 0.3667
N/A
_ Company Web Site ____________ Summary Pages ____________ 0.383:0.0:1


6.0: PBAXW : Phoenix Biotech Acquisition Corp. Warrants : ~ Price 0.021
N/A
_ Company Web Site ____________ Summary Pages ____________ 1e-06.000:0.0:1


6.0: PCCTW : Perception Capital Corp. II Warrants : ~ Price 0.1099
N/A
_ Company Web Site ____________ Summary Pages ____________ 1e-06.000:0.0:1


6.0: PPYAW : Papaya Growth Opportunity Corp. I Warrant : ~ Price 0.0109
N/A
_ Company Web Site ____________ Summary Pages ____________ 1e-06.000:0.0:1


5.0: AEACW : Authentic Equity Acquisition Corp. Warrant : ~ Price 0.0009

_ Company Web Site ____________ Summary Pages ____________ 0.570:6.0:2


5.0: CPAAW : Conyers Park III Acquisition Corp. Warrants : ~ Price 0.001

_ Company Web Site ____________ Summary Pages ____________ 0.890:4.0:2


5.0: AGGRW : Agile Growth Corp. Warrant. : ~ Price 0.003

_ Company Web Site ____________ Summary Pages ____________ 0.605:11.0:2


5.0: ADILW : Adial Pharmaceuticals Inc Warrant : ~ Price 0.0057

_ Company Web Site ____________ Summary Pages ____________ 0.410:7.0:2


5.0: AKLI : Akili Inc. Common Stock : ~ Price 0.4832

_ Company Web Site ____________ Summary Pages ____________ 4.810:2.0:3


5.0: ALORW : ALSP Orchid Acquisition Corporation I Warrant : ~ Price 0.0362
N/A
_ Company Web Site ____________ Summary Pages ____________ 1e-06.000:0.0:1


5.0: ARIZW : Arisz Acquisition Corp. Warrant : ~ Price 0.01
N/A
_ Company Web Site ____________ Summary Pages ____________ 1e-06.000:0.0:1


5.0: ARTEW : Artemis Strategic Investment Corporation Warrant : ~ Price 0.0351
N/A
_ Company Web Site ____________ Summary Pages ____________ 1e-06.000:0.0:1


5.0: ASCBW : A SPAC II Acquisition Corp. Warrant : ~ Price 0.005
N/A
_ Company Web Site ____________ Summary Pages ____________ 1e-06.000:0.0:1


5.0: ATAKW : Aurora Technology Acquisition Corp. Warrants : ~ Price 0.0112
N/A
_ Company Web Site ____________ Summary Pages ____________ 1e-06.000:0.0:1


5.0: AUROW : Aurora Innovation Inc. Warrant : ~ Price 0.2592
N/A
_ Company Web Site ____________ Summary Pages ____________ 0.211:0.0:1


5.0: KACLW : Kairous Acquisition Corp. Limited Warrants : ~ Price 0.0057
N/A
_ Company Web Site ____________ Summary Pages ____________ 1e-06.000:0.0:1


5.0: CCTSW : Cactus Acquisition Corp. 1 Limited Warrant : ~ Price 0.03
N/A
_ Company Web Site ____________ Summary Pages ____________ 1e-06.000:0.0:1


5.0: BRKHW : BurTech Acquisition Corp. Warrants : ~ Price 0.0161
N/A
_ Company Web Site ____________ Summary Pages ____________ 0.000:0.0:1


4.0: RCHGW : Recharge Acquisition Corp. Warrant : ~ Price 0.0001

_ Company Web Site ____________ Summary Pages ____________ 0.405:12.0:2


4.0: AKICW : Sports Ventures Acquisition Corp. Warrant : ~ Price 0.002

_ Company Web Site ____________ Summary Pages ____________ 0.425:8.0:2


4.0: SSAAW : Science Strategic Acquisition Corp. Alpha Warrant : ~ Price 0.0028

_ Company Web Site ____________ Summary Pages ____________ 0.380:5.0:2


4.0: AGILW : AgileThought Inc. Warrant : ~ Price 0.0042

_ Company Web Site ____________ Summary Pages ____________ 2.600:6.0:2


4.0: WALDW : Waldencast Acquisition Corp. Warrant : ~ Price 0.5025

_ Company Web Site ____________ Summary Pages ____________ 0.883:1.0:2


4.0: AIMDW : Ainos Inc. Warrants : ~ Price 0.3325

_ Company Web Site ____________ Summary Pages ____________ 1.737:3.0:2


4.0: AGEN : Agenus Inc. Common Stock : ~ Price 0.7309
Agenus is a clinical-stage immuno-oncology company focused on the discovery and development of therapies that engage the body's immune system to fight cancer. The Company's vision is to expand the patient populations benefiting from cancer immunotherapy by pursuing combination approaches that leverage a broad repertoire of antibody therapeutics, adoptive cell therapies (through its AgenTus Therapeutics subsidiary), and proprietary cancer vaccine platforms. The Company is equipped with a suite of antibody discovery platforms and a state-of-the-art GMP manufacturing facility with the capacity to support clinical programs. Agenus is headquartered in Lexington, MA.
_ Company Web Site ____________ Summary Pages ____________ 6.449:3.0:6


4.0: AMCIW : AMCI Acquisition Corp. II Warrant : ~ Price 0.3351

_ Company Web Site ____________ Summary Pages ____________ 4.459:34.0:1


4.0: AMPGW : Amplitech Group Inc. Warrants : ~ Price 0.303

_ Company Web Site ____________ Summary Pages ____________ 0.865:2.0:2


4.0: ADVM : Adverum Biotechnologies Inc. Common Stock : ~ Price 0.82
Adverum Biotechnologies is a clinical-stage gene therapy company targeting unmet medical needs in serious ocular and rare diseases. Adverum is advancing the clinical development of its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of patients with wet age-related macular degeneration and diabetic macular edema.
_ Company Web Site ____________ Summary Pages ____________ 10.443:6.0:3


4.0: ADVWW : Advantage Solutions Inc. Warrant : ~ Price 0.1308

_ Company Web Site ____________ Summary Pages ____________ 1.965:5.0:2


4.0: BCDAW : BioCardia Inc. Warrant : ~ Price 0.0601

_ Company Web Site ____________ Summary Pages ____________ 0.737:3.0:2


4.0: BGLC : BioNexus Gene Lab Corp Common stock : ~ Price 0.7546
N/A
_ Company Web Site ____________ Summary Pages ____________ 1.408:1.0:1


4.0: BLEUW : bleuacacia ltd Warrants : ~ Price 0.01
N/A
_ Company Web Site ____________ Summary Pages ____________ 1e-06.000:0.0:1


3.0: TEKKW : Tekkorp Digital Acquisition Corp. Warrant : ~ Price 0.0002

_ Company Web Site ____________ Summary Pages ____________ 1e-06.000:0.0:1


3.0: VPCBW : VPC Impact Acquisition Holdings II Warrant : ~ Price 0.001

_ Company Web Site ____________ Summary Pages ____________ 0.690:23.0:2


3.0: AGRIW : AgriFORCE Growing Systems Ltd. Warrant : ~ Price 0.0043

_ Company Web Site ____________ Summary Pages ____________ 1.060:5.0:2


3.0: KITTW : Nauticus Robotics Inc. Warrant : ~ Price 0.1837

_ Company Web Site ____________ Summary Pages ____________ 3.285:12.0:2


3.0: PEGY : Pineapple Holdings Inc. Common Stock : ~ Price 0.6998
Communications Systems, Inc., an IoT intelligent edge products and services company, provides network infrastructure and services for global deployments of enterprise and industrial networks. CSI operates under its Electronics & Software and Services & Support operating segments. Electronics & Software segment provides smart, flexible solutions at network edge, by giving customers the ability to easily provision and proactively manage their networks with actionable insights about their edge devices and connected end points, thereby minimizing the administrative burden of the operator. Services & Support segment provides fully managed services for all aspects of design, deployment, support and maintenance of customer networks. With partners and customers in over 50 countries, CSI has built a reputation as a reliable global innovator focusing on quality and customer service.
_ Company Web Site ____________ Summary Pages ____________ 19.941:3.0:3


3.0: SVVC : Firsthand Technology Value Fund Inc. Common Stock : ~ Price 0.4601
Firsthand Technology Value Fund, Inc. is a publicly traded venture capital fund that invests in technology and cleantech companies.
_ Company Web Site ____________ Summary Pages ____________ 23.296:16.0:3


3.0: SWAGW : Software Acquisition Group Inc. III Warrant : ~ Price 0.0601

_ Company Web Site ____________ Summary Pages ____________ 6.050:22.0:2


3.0: AACG : ATA Creativity Global American Depositary Shares : ~ Price 0.8201
ATA is focused on providing quality educational experiences and services for students throughout China and abroad. ATA aims to offer online, on-campus, and other education programs through a network of global education partners.
_ Company Web Site ____________ Summary Pages ____________ 10.098:4.0:5


3.0: GNS : Genius Group Limited Ordinary Shares : ~ Price 0.6397

_ Company Web Site ____________ Summary Pages ____________ 7.396:3.0:3


3.0: QRTEA : Qurate Retail Inc. Series A Common Stock : ~ Price 0.9421
Qurate Retail, Inc. operates and owns interests in a broad range of digital commerce businesses. Qurate Retail, Inc.'s businesses and assets consist of QVC (and its subsidiaries, including HSN), Zulily and the Cornerstone Brands (collectively, the Qurate Retail Group) as well as various green energy and other investments.
_ Company Web Site ____________ Summary Pages ____________ 4.175:2.0:6


3.0: AAU : Almaden Minerals Ltd. Common Shares : ~ Price 0.144
Almaden Minerals Ltd. owns 100% of the feasibility-stage Ixtaca project in Puebla State, Mexico, subject to a 2.0% NSR royalty held by Almadex Minerals Ltd. The Ixtaca Gold-Silver Deposit was discovered by Almaden in 2010.
_ Company Web Site ____________ Summary Pages ____________ 0.310:1.0:4


3.0: AGIL : AgileThought Inc. Class A Common Stock : ~ Price 0.1436
LIV Capital Acquisition Corp. was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The Company intends to focus on Mexican target businesses (or nonMexican target businesses with a significant presence in Mexico).
_ Company Web Site ____________ Summary Pages ____________ 5.492:1.0:5


3.0: VSSYW : Versus Systems Inc. Class A Warrants : ~ Price 0.02

_ Company Web Site ____________ Summary Pages ____________ 0.525:8.0:2


3.0: ALNA : Allena Pharmaceuticals Inc. Common Stock : ~ Price 0.1037
Allena Pharmaceuticals, Inc. is a late-stage biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class, oral biologic therapeutics to treat patients with rare and severe metabolic and kidney disorders. Allena's lead product candidate, reloxaliase, is currently being evaluated in a pivotal Phase 3 clinical program for the treatment of enteric hyperoxaluria, a metabolic disorder characterized by markedly elevated urinary oxalate levels and commonly associated with kidney stones, chronic kidney disease and other serious kidney disorders. Allena is also developing ALLN-346 for the treatment of hyperuricemia in the setting of gout and advanced chronic kidney disease, with a Phase 1 multiple-ascending dose study and a Phase 2a program planned for 2021.
_ Company Web Site ____________ Summary Pages ____________ 1.665:16.0:4


3.0: ALSAR : Alpha Star Acquisition Corporation Rights : ~ Price 0.1001

_ Company Web Site ____________ Summary Pages ____________ 5.930:35.0:2


3.0: VIRI : Virios Therapeutics Inc. Common Stock : ~ Price 0.57
Virios Therapeutics is a development-stage biotechnology company focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia ('FM'). Overactive immune response related to activation of tissue resident Herpes Simplex Virus-1 ('HSV-1') has been postulated to be a potential root cause of chronic illnesses such as FM, irritable bowel disease ('IBS'), chronic fatigue syndrome and functional somatic syndrome, all of which are characterized by a waxing and waning manifestation of disease. While not completely understood, there is general agreement in the medical community that activation of HSV-1 is triggered by some form of environmental and/or health stressor. Our lead development candidate ('IMC-1'), is a novel, proprietary, fixed dose combination of famciclovir and celecoxib. IMC-1 represents a novel combination antiviral therapy designed to synergistically suppress HSV-1 activation and replication, with the end goal of reducing viral mediated disease burden.
_ Company Web Site ____________ Summary Pages ____________ 1.260:4.0:2


3.0: AGTC : Applied Genetic Technologies Corporation Common Stock : ~ Price 0.376
Applied Genetic Technologies Corp. (AGTC) is a clinical-stage biotechnology company developing genetic therapies for people with rare and debilitating ophthalmic, otologic and central nervous system (CNS) diseases. AGTC is a leader in designing and constructing all critical gene therapy elements and bringing them together to develop customized therapies that address real patient needs. AGTC's most advanced clinical programs leverage its best-in-class technology platform to potentially improve vision for patients with an inherited retinal disease. AGTC has active clinical trials in X-linked retinitis pigmentosa (XLRP) and achromatopsia (ACHM CNGB3 and ACHM CNGA3). Its preclinical programs build on the Company's industry leading AAV manufacturing technology and scientific expertise. AGTC is advancing multiple important pipeline candidates to address substantial unmet clinical need in optogenetics, otology and CNS disorders. In recent years AGTC has entered into strategic partnerships with companies including Otonomy, a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, and Bionic Sight, an innovator in the emerging field of optogenetics and retinal coding.
_ Company Web Site ____________ Summary Pages ____________ 7.675:26.0:6


3.0: CETXW : Cemtrex Inc. Series 1 Warrant : ~ Price 0.0151

_ Company Web Site ____________ Summary Pages ____________ 0.120:8.0:1


3.0: ACONW : Aclarion Inc. Warrant : ~ Price 0.0299

_ Company Web Site ____________ Summary Pages ____________ 0.735:5.0:2


3.0: ACRX : AcelRx Pharmaceuticals Inc. Common Stock : ~ Price 0.6703
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. AcelRx's proprietary, non-invasive sublingual formulation technology delivers sufentanil with consistent pharmacokinetic profiles. AcelRx has one approved product in the U.S., DSUVIA® (sufentanil sublingual tablet, 30 mcg), known as DZUVEO™ in Europe, indicated for the management of acute pain severe enough to require an opioid analgesic for adult patients in certified medically supervised healthcare settings, and one product candidate, Zalviso® (sufentanil sublingual tablet system, SST system, 15 mcg), an investigational product in the U.S., is being developed as an innovatively designed patient-controlled analgesia (PCA) system for reduction of moderate-to-severe acute pain in medically supervised settings. DZUVEO and Zalviso are both approved products in Europe.
_ Company Web Site ____________ Summary Pages ____________ 2.888:12.0:6


3.0: ROCRW : Roth CH Acquisition III Co. Warrant : ~ Price 0.6398

_ Company Web Site ____________ Summary Pages ____________ 0.744:1.0:2


3.0: AFMD : Affimed N.V. : ~ Price 0.5419
Affimed is a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer by actualizing the untapped potential of the innate immune system. The company's proprietary ROCK® platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly-owned and partnered single agent and combination therapy programs. The ROCK platform predictably generates customized innate cell engager (ICE®) molecules, which use patients' immune cells to destroy tumor cells. This innovative approach enabled Affimed to become the first company with a clinical-stage ICE®. Headquartered in Heidelberg, Germany, with offices in New York, New York, Affimed is led by an experienced team of biotechnology and pharmaceutical leaders united by a bold vision to stop cancer from ever derailing patients' lives.
_ Company Web Site ____________ Summary Pages ____________ 6.985:3.0:6


3.0: AIH : Aesthetic Medical International Holdings Group Ltd. American Depositary Shares : ~ Price 0.6946
Aesthetic Medical International Holdings Group Limited, founded in Shenzhen, China in 1997, is an international listed group specialized in aesthetic medical services as well as the first aesthetic medical services organization listed in China's main board. AIH has always prioritized the safety and quality of aesthetic services, making it one of aesthetic services institutions with the best medical safety records as well as with the longest history in the industry and thus enjoying prestige in the society and among consumers.
_ Company Web Site ____________ Summary Pages ____________ 7.680:3.0:4


3.0: ADERW : 26 Capital Acquisition Corp. Warrant : ~ Price 0.012

_ Company Web Site ____________ Summary Pages ____________ 0.750:3.0:1


3.0: ADOCR : Edoc Acquisition Corp. Right : ~ Price 0.10

_ Company Web Site ____________ Summary Pages ____________ 0.220:1.0:2


3.0: ADOCW : Edoc Acquisition Corp. Warrant : ~ Price 0.0166

_ Company Web Site ____________ Summary Pages ____________ 0.125:3.0:2


3.0: AGBAR : AGBA Acquisition Limited Right : ~ Price 0.3999

_ Company Web Site ____________ Summary Pages ____________ 0.210:2.0:2


3.0: AGBAW : AGBA Acquisition Limited Warrant : ~ Price 0.0353

_ Company Web Site ____________ Summary Pages ____________ 0.145:3.0:2


3.0: ALACR : Alberton Acquisition Corporation Rights exp April 26 2021 : ~ Price 0.0703

_ Company Web Site ____________ Summary Pages ____________ 0.337:5.0:2


3.0: ALACW : Alberton Acquisition Corporation Warrant : ~ Price 0.0225

_ Company Web Site ____________ Summary Pages ____________ 0.340:15.0:1



Curiosity Stocks - Price range: $1 - $5
List of Curiosity Stocks - Price range: $1 - $5
Curiosity Stocks - Price range: $5 - $10
List of Curiosity Stocks - Price range: $5 - $10
Curiosity Stocks - Price range: $10 - $50
List of Curiosity Stocks - Price range: $10 - $50
Curiosity Stock Price range: $50 - $100
List of Curiosity Stocks - Price range: $50 - $100








INDEX









Page design by: TRoach